ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.74B
Enterprise Value 37.97B
Trailing P/E N/A
Forward P/E 1-11.98
PEG Ratio (5 yr expected) 1-0.23
Price/Sales (ttm)116.61
Price/Book (mrq)6.38
Enterprise Value/Revenue 3106.35
Enterprise Value/EBITDA 6-9.86

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,087.56%

Management Effectiveness

Return on Assets (ttm)-28.53%
Return on Equity (ttm)-49.63%

Income Statement

Revenue (ttm)74.91M
Revenue Per Share (ttm)0.75
Quarterly Revenue Growth (yoy)-44.50%
Gross Profit (ttm)73.11M
EBITDA -808.24M
Net Income Avi to Common (ttm)-761.5M
Diluted EPS (ttm)-7.57
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.08B
Total Cash Per Share (mrq)10.2
Total Debt (mrq)30M
Total Debt/Equity (mrq)2.30
Current Ratio (mrq)6.69
Book Value Per Share (mrq)12.87

Cash Flow Statement

Operating Cash Flow (ttm)-562.62M
Levered Free Cash Flow (ttm)-475.89M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.44
52-Week Change 3-11.44%
S&P500 52-Week Change 38.62%
52 Week High 3124.22
52 Week Low 360.27
50-Day Moving Average 388.42
200-Day Moving Average 381.11

Share Statistics

Avg Vol (3 month) 3765.82k
Avg Vol (10 day) 3815.18k
Shares Outstanding 5106.44M
Float 94.81M
% Held by Insiders 110.78%
% Held by Institutions 188.18%
Shares Short (Mar 29, 2019) 45.35M
Short Ratio (Mar 29, 2019) 47.26
Short % of Float (Mar 29, 2019) 49.10%
Short % of Shares Outstanding (Mar 29, 2019) 45.03%
Shares Short (prior month Feb 28, 2019) 45.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A